BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35046284)

  • 21. [A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
    Takaya K; Takahashi R; Honma S; Horii S; Takahashi H; Hagiwara M; Chin M; Hashizume E
    Gan To Kagaku Ryoho; 2016 Sep; 43(9):1113-6. PubMed ID: 27628555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case of HER2-Positive Unresectable Gastric Cancer with Multiple Lymph Node and Liver Metastases Controlled Effectively by Combination Chemotherapy with Capecitabine, Oxaliplatin, and Trastuzumab].
    Sato N; Nakayama A; Takai Y; Kamata T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1266-1268. PubMed ID: 29394602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperprogressive Disease during Treatment with Nivolumab for Recurrence of Gastric Cancer].
    Takeoka T; Okada K; Matsuno H; Konishi K; Ota H; Yokoyama S; Fukunaga M; Kobayashi K
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):165-167. PubMed ID: 32381893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
    Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
    Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two Cases of Advanced Gastric Cancer with Para‒Aortic Lymph Node Metastasis or Recurrence for Which Nivolumab Therapy Were Effective].
    Kidogami S; Endo S; Tamura S; Murotani M; Shigetsu K; Yoneda N; Imamura H; Mokutani Y; Kishimoto T; Hashimoto Y; Hirose H; Yoshioka S; Sasaki Y
    Gan To Kagaku Ryoho; 2021 Apr; 48(4):575-577. PubMed ID: 33976053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
    Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Long Survival with Hilar Lymph Node Metastasis from Gastric Cancer Successfully Treated with Nivolumab Immunotherapy].
    Okada K; Takeoka T; Kobayashi K; Fukunaga M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2315-2317. PubMed ID: 32156916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of Unresectable Gastric Mixed Neuroendocrine Neoplasm(MiNEN)Treated with Chemotherapy].
    Suemori K; Uno F; Hisamatsu K; Mizuno D; Miyauchi S; Iga N; Yoshida R; Kawai H; Ishizaki M; Nishi H
    Gan To Kagaku Ryoho; 2022 Jan; 49(1):59-61. PubMed ID: 35046363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreaticoduodenectomy after neoadjuvant chemotherapy for gastric cancer invading the pancreatic head: A case report.
    Yura M; Takano K; Adachi K; Hara A; Hayashi K; Tajima Y; Kaneko Y; Ikoma Y; Fujisaki H; Hirata A; Hongo K; Yo K; Yoneyama K; Dehari R; Koyanagi K; Nakagawa M
    World J Gastroenterol; 2021 Feb; 27(6):534-544. PubMed ID: 33642827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
    Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
    Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Case of Unresectable Local Recurrence of Gastric Cancer Successfully Resected after Pre-Operative Chemotherapy with Trastuzumab].
    Okubo S; Takahashi T; Miyazaki Y; Makino T; Kurokawa Y; Yamazaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2094-6. PubMed ID: 26805275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of curative surgery for HER2-positive gastric cancer after chemotherapy using paclitaxel combined with trastuzumab].
    Okubo S; Kawabata R; Kimura Y; Kawase T; Ishigaki T; Amano K; Munakata S; Fukunaga M; Ohzato H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2302-4. PubMed ID: 25731503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Case of Liver Metastasis of Gastric Cancer Successfully Treated with SOX plus Nivolumab].
    Ueno M; Endo S; Hori M; Kageyama C; Iwamoto R; Kinoshita S; Kitagawa S; Mineta S; Kanesada K; Higashida M; Ito Y; Okada T; Yoshimatsu K; Fujiwara Y; Ueno T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1813-1815. PubMed ID: 38303216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A Case of Long-Term Survival Achieved after Nivolumab Treatment for Recurrence of Postoperative Advanced Gastric Cancer].
    Suzuki T; Musha H; Kamio Y; Hachiya O; Motoi F
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1895-1897. PubMed ID: 35045439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Patient with HER2-Positive Stage IV Advanced Gastric Cancer Who Received Chemotherapy with Trastuzumab plus XP Followed by Conversion Surgery].
    Yamamoto K; Yamamoto K; Maeda S; Uemura M; Miyake M; Hama N; Nishikawa K; Miyamoto A; Omiya H; Miyazaki M; Ikeda M; Hirao M; Takami K; Nakamori S; Sekimoto M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1942-1944. PubMed ID: 28133183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Unresectable Advanced HER2-Positive Gastric Cancer Leading to a Perforation during Chemotherapy with Trastuzumab plus Paclitaxel].
    Ogawa T; Watanabe M; Doita S; Minagi H; Miyake E; Hatono M; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Aoki H
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1452-1454. PubMed ID: 36733099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trastuzumab Combination Chemotherapy Followed by R0 Resection for Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer-A Case Report].
    Takenoya T; Yabe N; Morishige S; Tamura E; Sakimoto Y; Tajima Y; Oto I; Yoshikawa T; Osumi K; Murai S
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):121-123. PubMed ID: 30765661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
    Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
    BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of stage IV gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab].
    Nakayama Y; Kawasaki H; Wajima N; Kimura A; Nakai M; Yonaiyama S; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2188-90. PubMed ID: 24394055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.